CAREDX INC. - COMMON

CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant Patients

02 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

CareDx Reports Fourth Quarter and Full Year 2021 Results

24 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation

22 фев 2022 07:00:02 Источник Nasdaq GlobeNewswire

CareDx to Report Fourth Quarter and Full Year 2021 Financial Results

17 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a Transplant

14 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Taps into Its Patient Network to Deliver Insights on Transplant Needs

08 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire

CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host “Heart Health” Webinar for Transplant Patients

07 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx To Participate In Upcoming Conferences

03 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities

20 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance

12 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies

11 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021

10 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection

07 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch

06 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy

05 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients

04 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes

16 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study

13 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire

CareDx The Transplant Company Surpasses 80,000 Patient Milestone

02 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire

CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500™ for the Third Consecutive Year

19 ноя 2021 07:00:00 Источник Nasdaq GlobeNewswire